Search For Lab Tests Here

The Alpha-Fetoprotein (AFP) and AFP-L3 Test measures total AFP and the AFP-L3 fraction, which is more specific for liver cancer risk. Elevated AFP may indicate liver disease, germ cell tumors, or hepatitis, while AFP-L3 is strongly associated with hepatocellular carcinoma (HCC). Doctors order this test to assess liver function, screen high-risk patients, and monitor cancer treatment. Results provide critical insight into liver health and cancer detection.

The Preventive Health & Cancer Screening Support - Comprehensive Male Lab Panel includes 22 tests and 125 biomarkers to support physician-guided review of preventive wellness and selected cancer marker support labs for men. It includes CBC, CMP, FIT/InSure®, PSA free and total, AFP/AFP-L3, CEA, CA 19-9, hepatitis, liver, kidney, thyroid, iron, inflammation, urinalysis, vitamin D, lipids, glucose, cystatin C, and immune protein labs.

The Preventive Health & Cancer Marker Lab Panel - Advanced Male includes 19 tests and 114 biomarkers to support physician-guided review of preventive wellness and selected cancer marker patterns. It includes CBC, CMP, FIT/InSure®, PSA free and total, AFP/AFP-L3, CEA, CA 19-9, liver, kidney, thyroid, iron, inflammation, urinalysis, vitamin D, lipids, glucose, cystatin C, urine albumin, GGT, bilirubin, ferritin, and iron/TIBC.

The Preventive Health & Cancer Marker Lab Panel — Comprehensive Female includes 27 tests and 137 biomarkers to support physician-guided review of preventive wellness and selected cancer marker support labs for women. It includes CBC, CMP, FIT/InSure®, liver, kidney, thyroid, iron, inflammation, hepatitis, urinalysis, vitamin D, lipids, glucose, immune protein markers, and tumor marker support labs such as CA 125, CA 15-3, CA 27.29, CA 19-9, CEA, and AFP/AFP-L3.

The CA 15-3 Test measures cancer antigen 15-3 levels in blood, often used to monitor breast cancer treatment and progression. Elevated levels may suggest advanced breast cancer, metastasis, or recurrence, while non-cancer conditions can also affect results. Doctors order this test alongside imaging and other labs to track therapy response or detect changes in disease status. Results help guide ongoing management of breast cancer and patient care.

The Preventive Health & Cancer Marker Lab Panel - Advanced Female includes 23 tests and 116 biomarkers to support physician-guided review of preventive wellness and selected cancer marker patterns. It includes CBC, CMP, FIT/InSure®, CA 125, CA 15-3, CA 27.29, CA 19-9, CEA, AFP/AFP-L3, kidney, liver, thyroid, iron, inflammation, urinalysis, vitamin D, lipids, glucose, cystatin C, urine albumin, GGT, bilirubin, ferritin, and Free T3/T4.

The Lactate Dehydrogenase (LDH) Isoenzyme Panel measures total LDH and separates it into isoenzymes (LDH-1 to LDH-5) to identify tissue damage. LDH-1 is linked to heart, LDH-2 to blood, LDH-3 to lungs, LDH-4 to kidneys, and LDH-5 to liver and muscle. Elevated levels may indicate heart attack, liver disease, anemia, or cancer. Doctors order this test to pinpoint tissue injury, monitor disease progression, and guide treatment strategies.

The CA 125 Test measures the level of cancer antigen 125 in blood, a protein often elevated in ovarian cancer and some other conditions. While not used alone for diagnosis, it helps monitor treatment effectiveness, detect recurrence, or assess disease progression. Elevated CA 125 may also be seen in endometriosis, fibroids, or pelvic inflammation. Doctors use this test to support cancer management and track overall reproductive and abdominal health.

The CA 19-9 Test measures levels of carbohydrate antigen 19-9 in blood, a tumor marker often elevated in pancreatic cancer and sometimes in bile duct, colorectal, or liver cancers. While not used alone for diagnosis, it helps monitor treatment, track disease progression, and detect recurrence. Elevated CA 19-9 may also occur in noncancerous conditions. Doctors use this test to support cancer management and guide therapy decisions.

The Liver and Kidney Function Panel measures blood sugar, electrolytes, proteins, and markers of liver and kidney health. It helps detect disease, monitor conditions, and guide treatment decisions.

The Chromogranin A Test measures levels of chromogranin A, a protein often elevated in neuroendocrine tumors. It helps doctors monitor tumor presence, treatment response, and recurrence. Elevated results may also occur with conditions such as chronic atrophic gastritis, inflammatory diseases, or use of proton pump inhibitors. Combined with imaging and other tumor markers, this test supports the diagnosis and management of neuroendocrine disorders.

The hCG Test with Gestational Table is a blood test that tracks human chorionic gonadotropin to confirm pregnancy and assess fetal growth. Comparing results with gestational reference ranges helps evaluate maternal health, monitor early development, and identify potential complications such as ectopic pregnancy, miscarriage, or abnormal hormone trends linked to reproductive health.